Navigation Links
Garry W. Rogerson Elected Chairman of the Board of Varian, Inc.
Date:2/9/2009

PALO ALTO, Calif., Feb. 9 /PRNewswire-FirstCall/ -- Varian, Inc. (NasdaqGS: VARI) today reported that its Board of Directors has elected Garry W. Rogerson, the company's President and Chief Executive Officer, as Chairman of the Board. He replaces Allen J. Lauer, who retired from the Board upon expiration of his director term at the annual meeting of stockholders held on February 5, 2009. Rogerson will continue as the company's Chief Executive Officer.

"We were very fortunate to have had Al as our chairman following his retirement as chief executive officer in 2003," said Rogerson. "With his more than forty years of service with Varian, he provided wise counsel and guidance to the Board as well as the management team."

Rogerson joined Varian Associates, Inc. (Varian, Inc.'s predecessor company) in 1979, and held numerous management positions before being appointed chief executive officer in 2004. He has served as the company's president since 2002, and served as chief operating officer from 2002 to 2004, as senior vice president of its scientific instruments business from 2001 to 2002, and as vice president of its analytical instruments business from 1999 to 2001. Rogerson has been a director of the Company since 2003. He is also the non-executive Chairman of the Board of Coherent, Inc. Rogerson earned his Ph.D. in biochemistry from the University of Kent at Canterbury, England.

Varian, Inc. is a leading worldwide supplier of scientific instruments and vacuum technologies for life science, environmental, energy, and applied research and other applications. The company provides complete solutions, including instruments, vacuum products, laboratory consumable supplies, software, training and support through its global distribution and support systems. Varian, Inc. employs approximately 3,700 people worldwide and operates manufacturing facilities in North America, Europe and Asia Pacific. Varian, Inc. had fiscal year 2008 sales of $1.0 billion, and its common stock is traded on the NASDAQ Global Select Market under the symbol "VARI." Further information is available on the company's Web site at http://www.varianinc.com.

     For More Information, Contact:
     Investor Relations
     Varian, Inc.
     650.424.5471
     ir@varianinc.com

'/>"/>
SOURCE Varian, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Executive Chairman of Medifast Bradley MacDonald Selected to Participate in Leadership Maryland
2. Delfigo Security Selected as One of Twenty Five Most Promising Startups by The Wharton Entrepreneurship Conference
3. Dallas – Fort Worth Bariatric Surgeon Dr. David Kim One of Few in America Selected to Perform New Weight Loss Surgery Procedure
4. Wesley Mosley Selected to Participate in Global Youth Activation Summit During the 2009 Special Olympics World Winter Games
5. EDI Health Group Selected by Quality Systems to Facilitate EDI Transactions Between Payers and Large Dental Group Practices
6. Bruce E. Mosler, President and CEO of Cushman & Wakefield Elected to CASA* Board
7. Quantros Director of Patient Safety and Risk Management is Elected Co-Chair of Patient Safety Work Group (PSWG) at HL7
8. Turner Selected to Construct Replacement Hospital for University Medical Center at Princeton
9. Phylicia Rashad Selected as New Spokesperson for Jenny Craig
10. Quantros Director of Patient Safety and Risk Management is Elected Co-Chair of Patient Safety Special Interest Group (PSSIG) at HL7
11. Charles Drew University executive vice president selected to be Research!America ambassador
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... Somnoware, a leading provider ... Online(TM), which enables sleep physicians to create and edit their interpretation reports. This ... provides a familiar interface that does not require additional training to use. It ...
(Date:4/28/2017)... NY (PRWEB) , ... April 28, 2017 , ... ... Laboratory to expanded distribution of the GlycoMark test throughout the Northeast U.S. ... hyperglycemia in patients with diabetes. The GlycoMark test provides a clinically proven one- ...
(Date:4/28/2017)... york (PRWEB) , ... April 28, 2017 , ... ... to announce that Aditya Patel M.D. has joined the revolutionary endoscopic practice under ... and board certification in Interventional Pain Medicine. The patented, revolutionary eDiscSculpt Technique created ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early detection and ... drug safety and minimize the cost of development. In this webinar, sponsored by ... cell lines and for cardiac toxicity using induced pluripotent stem cells (iPSCs). , ...
(Date:4/28/2017)... ... April 28, 2017 , ... Researchers at ... ActiGraph’s CentrePoint Data Hub in a sample of participants enrolled in ... activity and sleep monitoring solutions for the global scientific community. The company’s new ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 19, 2017 Global Prostate Cancer Therapeutics ... the prostate cancer therapeutics market analyzes the current ... prevalence of prostate cancer, launch of promising emerging ... of new drugs & therapeutic biological products, and ... to lesser side effects are some of the ...
(Date:4/19/2017)... The Global Effective Microorganisms (EM) Market by Manufacturers, ... and analysed the potential of Global Effective Microorganisms (EM) Market ... growth factors. The report identifies and analyses the emerging trends ... market. ... and Figures, 6 Major Company Profiles, spread across 124 pages ...
(Date:4/19/2017)... Companion animal vaccines ... pets such as canine, avian and feline. ... such as Attenuated Live Vaccines, Conjugate Vaccines, Inactivated ... Recombinant Vaccines. Attenuated live vaccines are derived from ... have been weakend under laboratory conditions. Conjugate vaccines ...
Breaking Medicine Technology: